Sphere Medical - Capital Network: Monitoring System that Could be Transformational
Sphere Medical is launching Proxima 4, the first patient-attached blood gas and electrolytes (BGE) monitoring system on the market, which could transform the way critically ill patients are treated.
With cash-on-hand of £3.2 million as of December 2016 (vs £10.0 million at end-2015), we would expect the company to raise capital in the course of 2017, likely through a rights issue or convertible notes.
Quick facts: Sphere Medical Holding PLC
Market Cap: £0.00
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE
LEGAL NOTICE – IMPORTANT – PLEASE READ:
Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...FOR OUR FULL DISCLAIMER CLICK HERE